Elk River Wealth Management’s AbbVie ABBV Stock Holding History

Elk River Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.14M	Buy	5,227 +17	+0.3%	+$3.77K	0.19%	54
2025 Q4	$1.19M	Hold	5,210	–	–	0.19%	51
2025 Q3	$1.21M	Hold	5,210	–	–	0.19%	50
2025 Q2	$967K	Sell	5,210 -185	-3%	-$34.4K	0.17%	53
2025 Q1	$1.13M	Sell	5,395 -216	-4%	-$42K	0.21%	49
2024 Q4	$997K	Hold	5,611	–	–	0.18%	50
2024 Q3	$1.11M	Sell	5,611 -30	-0.5%	-$5.6K	0.2%	50
2024 Q2	$968K	Hold	5,641	–	–	0.19%	49
2024 Q1	$1.03M	Sell	5,641 -1,523	-21%	-$262K	0.21%	49
2023 Q4	$1.11M	Hold	7,164	–	–	0.21%	53
2023 Q3	$1.07M	Hold	7,164	–	–	0.24%	50
2023 Q2	$965K	Sell	7,164 -17	-0.2%	-$2.49K	0.21%	51
2023 Q1	$1.14M	Sell	7,181 -592	-8%	-$90.5K	0.26%	50
2022 Q4	$1.26M	Sell	7,773 -94	-1%	-$14.4K	0.3%	54
2022 Q3	$1.06M	Sell	7,867 -163	-2%	-$23.4K	0.28%	55
2022 Q2	$1.23M	Hold	8,030	–	–	0.31%	57
2022 Q1	$1.3M	Sell	8,030 -271	-3%	-$39.4K	0.28%	57
2021 Q4	$1.12M	Buy	8,301 +741	+10%	+$87.5K	0.25%	56
2021 Q3	$815K	Sell	7,560 -178	-2%	-$20.3K	0.21%	62
2021 Q2	$872K	Sell	7,738 -37	-0.5%	-$4.17K	0.23%	64
2021 Q1	$841K	Buy	7,775 +225	+3%	+$24.1K	0.24%	62
2020 Q4	$809K	Buy	+7,550	New	+$726K	0.27%	64

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Elk River Wealth Management's ABBV Position: Q1 2026 in Review

Elk River Wealth Management increased its AbbVie (ABBV) stake by 0.33% in Q1 2026, buying an estimated $3.77K and bringing the position to 5,227 shares worth $1.14M. The position accounts for 0.19% of the portfolio, ranked #54.

Elk River Wealth Management first reported a position in ABBV in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.3M in Q1 2022. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Elk River Wealth Management held 5,227 shares of AbbVie worth $1.14M as of Q1 2026.
Elk River Wealth Management bought 17 AbbVie shares in Q1 2026, an estimated $3.77K.
AbbVie made up 0.19% of Elk River Wealth Management's portfolio in Q1 2026, its #54 holding.
Elk River Wealth Management first reported a position in AbbVie in Q4 2020 and has held it in 22 quarters since.
Elk River Wealth Management's AbbVie position peaked at $1.3M in Q1 2022.
4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Elk River Wealth Management's 13F filing for Q1 2026, filed 17 Apr 2026.